Skip to main content

Table 2 Comparison of plasma kallistatin and kallikrein levels between patients with severe community-acquired pneumonia and healthy individuals

From: Plasma kallistatin levels in patients with severe community-acquired pneumonia

 

Normal subjects

(n= 17)

Patients

(n= 54)

  

Day 1

Day 4

Kallistatin (μg/ml)

17.2 (5.3-82.7)

8.3 (1.3-17.3)a

11.0 (1.8-18.3)b

Kallikrein (pg/ml)

276.9 (0-1,494.5)

203.4 (16.5-4,459.9)

164.3 (8.6-3,307.4)

  1. Data are presented as median (range). aDay 1 plasma kallistatin levels of patients were compared with those of normal subjects; P < 0.001. bDay 4 plasma kallistatin levels of patients were compared with those of normal subjects; P < 0.001.